Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 5.


Watts, Colin, Ashkan, Keyoumars, Jenkinson, Michael D ORCID: 0000-0003-4587-2139, Price, Stephen J, Santarius, Thomas, Matys, Tomasz, Zhang, Ting Ting, Finch, Alina, Collins, Peter, Allinson, Kieren
et al (show 8 more authors) (2021) An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma. CANCERS, 13 (13). 3241-.


Jefferson, Emily, Cole, Christian, Mumtaz, Shahzad, Cox, Samuel, Giles, Thomas Charles, Adejumo, Sam, Urwin, Esmond, Lea, Daniel, Macdonald, Calum, Best, Joseph
et al (show 68 more authors) (2022) A Hybrid Architecture (CO-CONNECT) to Facilitate Rapid Discovery and Access to Data Across the United Kingdom in Response to the COVID-19 Pandemic: Development Study. JOURNAL OF MEDICAL INTERNET RESEARCH, 24 (12). e40035-.


Yao, Sheng, Bee, Alix, Brewer, Daniel ORCID: 0000-0003-4753-9794, Dodson, Andrew, Beesley, Carol, Ke, Youqiang ORCID: 0000-0001-5341-8644, Ambroisine, Laurence, Fisher, Gabrielle, Møller, Heinrich ORCID: 0000-0001-8200-5929, Dickinson, Tim
et al (show 13 more authors) (2010) PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention. Genes & cancer, 1 (5). pp. 444-464.


Lenti, Marco Vincenzo, Dolby, Vivien, Clark, Tanya, Hall, Veronica, Tattersall, Suzanne, Fairhurst, Francesca, Kenneth, Catherine, Walker, Rachael, Kemp, Karen, Borg-Bartolo, Simon
et al (show 11 more authors) (2022) A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55 (7). pp. 856-866.


Lenti, Marco Vincenzo, Levison, Scott, Eliadou, Elena, Willert, Robert, Kemp, Karen, Carter, Anna, Stansfield, Catherine, Assadsangabi, Arash, Singh, Salil, Crooks, Ben
et al (show 13 more authors) (2018) A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study. DIGESTIVE AND LIVER DISEASE, 50 (12). pp. 1299-1304.

This list was generated on Sun Mar 3 17:53:13 2024 GMT.